Avid Bioservices, a CDMO focused on biopharmaceutical products derived from mammalian cell culture, has advanced the ongoing expansion of its process development capabilities and labs, initiating demolition work at the site that will ultimately provide an additional 3,000 sq.-ft. of space. The newly constructed lab will allow for the consolidation of cell line development, upstream process development and upstream pilot scale production in a single location with the latest equipment.  Once co...